1H-Indazole-3-carboxamide - CAS 90004-04-9
Catalog: |
BB039732 |
Product Name: |
1H-Indazole-3-carboxamide |
CAS: |
90004-04-9 |
Synonyms: |
1H-indazole-3-carboxamide; 1H-indazole-3-carboxamide |
IUPAC Name: | 1H-indazole-3-carboxamide |
Description: | 1H-Indazole-3-carboxamide (CAS# 90004-04-9) is a useful research chemical. |
Molecular Weight: | 161.16 |
Molecular Formula: | C8H7N3O |
Canonical SMILES: | C1=CC=C2C(=C1)C(=NN2)C(=O)N |
InChI: | InChI=1S/C8H7N3O/c9-8(12)7-5-3-1-2-4-6(5)10-11-7/h1-4H,(H2,9,12)(H,10,11) |
InChI Key: | DITBWPUMEUDVLU-UHFFFAOYSA-N |
LogP: | 1.36210 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-10907163-B1 | Aptamers that bind to natural and synthetic cannabinoids | 20200615 |
WO-2021125802-A1 | Novel indazole derivative, and use thereof | 20191216 |
WO-2021067654-A1 | Indazole carboxamides as kinase inhibitors | 20191003 |
WO-2021055906-A1 | Injection systems and methods of their use | 20190920 |
WO-2021055672-A1 | Compositions of cannabinoids for delivery by inhalation | 20190918 |
PMID | Publication Date | Title | Journal |
32688070 | 20200901 | The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice | Drug and alcohol dependence |
30280499 | 20190301 | Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors | Drug testing and analysis |
22177599 | 20120401 | Design and synthesis of N-substituted indazole-3-carboxamides as poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors(†) | Chemical biology & drug design |
17201405 | 20070111 | Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors | Journal of medicinal chemistry |
Complexity: | 195 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 161.058911855 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 161.058911855 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 71.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS